Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stepped-wedge Design Study of Point-of-care Molecular Testing for Influenza and Treatment With Baloxavir for Prevention of Secondary Transmission of Influenza in Homeless Shelters in Seattle, WA

NCT04141917 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT04141917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04141917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stepped-wedge Design Study of Point-of-care Molecular Testing for Influenza and Treatment With Baloxavir for Prevention of Secondary Transmission of Influenza in Homeless Shelters in Seattle, WA
Lead sponsor
University of Washington
Phase
Phase 4
Overall status
Terminated
Start date
November 15, 2019
Completion date
March 31, 2021
Enrollment
1,618 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

influenza, respiratory viral infection